Copyright
©The Author(s) 2018.
World J Gastroenterol. May 28, 2018; 24(20): 2191-2202
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2191
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2191
Figure 4 Effect of antiviral therapy on serum CXCL10 levels of IL-28 rs12979860 C/C patients with different CXCL10 G-201A single nucleotide polymorphisms.
A: The baseline serum CXCL10 levels of IL-28 rs12979860 C/C patients who completed the Peg-IFNα plus ribavirin treatment; B-C: The serum CXCL10 levels of the patients at the endpoint of antiviral treatment (B) and at 24 wk follow up (C); aP < 0.0001; bP = 0.038; cP = 0.008; dP = 0.008; eP = 0.009. OCI: Occult hepatitis C virus infection; CHC: Chronic hepatitis C virus infection.
- Citation: Wang X, Wang S, Liu ZH, Qi WQ, Zhang Q, Zhang YG, Sun DR, Xu Y, Wang HG, Li ZX, Cong XL, Zhao P, Zhou CY, Wang JB. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection. World J Gastroenterol 2018; 24(20): 2191-2202
- URL: https://www.wjgnet.com/1007-9327/full/v24/i20/2191.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i20.2191